Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-09

Clinical Trial Update: Phase 3 Study of Pelubiprofen Tab. & Celebrex Cap. in Rheumatoid Arthritis Patients [Phase 3]

View source ↗

Summary

A Phase 3 study comparing pelubiprofen tablets with Celebrex capsules in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CELEBREX (Celecoxib)
  • Pelubiprofen (pelubiprofen)

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Pelubiprofen, Celebrex | Phase 3 | Status: COMPLETED